Semaglutide was initially designed to control blood sugar in diabetic patients, as it stimulates insulin secretion to regulate blood sugar
That may be related to the possibility that people, when they are on GLP-1, they definitely eat a whole lot less to lose weight, but they also hydrate themselves less, Al-Aly said in a news briefing
Any therapy that sustains high IGF-1 raises a theoretical concern about promoting the growth of existing or nascent tumors
However, it's important to note that the effectiveness of peptide supplementation can depend on various factors, including the type of peptides used, the individual's health status, and the presence of other interventions
Therefore, we propose that the role of IGF-1 in this process lies more on the maintenance of a normal pace of proliferation rather than in the initiation of cell division (Wang et al., 2006b)
It works by blocking enzymes called COX-1 and COX-2